EPISODE · May 6, 2026 · 6 MIN
Bayer Acquires Perfuse in $2.45 Billion Deal
from Eyewire News: The Podcast · host Eyewire News
Bayer expands ophthalmology pipeline with acquisiton of Perfuse Therapeutics; Viridian announces new phase 3 data for its investigational subcutaneous injection for chronic thyroid eye disease; and Steven Dell, MD discusses the impact of declining reimbursement could on ophthalmic practices. Learn more about your ad choices. Visit megaphone.fm/adchoices
NOW PLAYING
Bayer Acquires Perfuse in $2.45 Billion Deal
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m